CT26-hNECTIN4
Strain Information
Validation Data
Fig1. NECTIN4 expression expression in CT26-hNECTIN4 cell lines.
Fig2. In vivo validation of CT26-hNECTIN4 in BALB/c mice.
BALB/c mice were inoculated with CT26-hNECTIN4 subcutaneously at 3×106 cells/mouse inoculum for tumor development.
Fig3. NECTIN4 expression in tumors after in vivo growth of CT26-hNECTIN4 in wild type BALB/c mice.
Fig4. NECTIN4 expression in tumors after in vivo growth of CT26-hNECTIN4 in wild type BALB/c mice.
Related Strain(s)
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreOur vision is to provide researchers all over the world with comprehensive, convenient and professional animal model services to facilitate a simplified and highly-efficient approach towards uncovering the mysteries of life.
Learn more